Table 2 Â A breakdown of the number of patients in both the experimental and control cohort following the matching process
Population | Testosterone Use, n (%) | Control Cohort, n (%) | |
|---|---|---|---|
Sex | Age | ||
All Patients | Â | 423,278 (100.0) | 423,278 (100.0) |
Male | Â | 345,369 (81.6) | 345,369 (81.6) |
35 to 45 | 80,608 (19.0) | 80,608 (19.0) | |
46 to 55 | 103,754 (24.5) | 103,754 (24.5) | |
56 to 65 | 92,961 (22.0) | 92,961 (22.0) | |
66 to 75 | 68,046 (16.1) | 68,046 (16.1) | |
Female | Â | 77,909 (18.4) | 77,909 (18.4) |
35 to 45 | 10,120 (2.4) | 10,120 (2.4) | |
46 to 55 | 28,320 (6.7) | 28,320 (6.7) | |
56 to 65 | 28,185 (6.7) | 28,185 (6.7) | |
66 to 75 | 11,284 (2.7) | 11,284 (2.7) | |